Article (Scientific journals)
Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?
Mamas, Mamas A.; Deaton, Christi; Rutter, Martin K. et al.
2010In Journal of Cardiac Failure, 16 (9), p. 761-8
Peer Reviewed verified by ORBi
 

Files


Full Text
Impaired glucose tolerance and insulin resistance in heart failure - underrecognized and undertreated.pdf
Publisher postprint (269.44 kB)
Request a copy

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
Blood Glucose/metabolism; Fatty Acids/metabolism; Glucose Intolerance/physiopathology; Heart Failure/physiopathology; Humans; Hypoglycemic Agents/therapeutic use; Incretins/therapeutic use; Insulin Resistance/physiology; Metabolic Syndrome X/physiopathology; Metformin/therapeutic use; Myocardium/metabolism; Prognosis; Risk Factors; Treatment Outcome
Abstract :
[en] BACKGROUND: A link between diabetes mellitus (DM) and heart failure (HF) has been well-recognized for more than a century. HF is also closely linked to abnormal glucose regulation (AGR) and insulin resistance (IR) in patients without DM and, similarly, these conditions commonly coexist. In epidemiological studies, each condition appears to predict the other. The prevalence of AGR/IR in HF patients without DM is significantly underrecognized and, as yet, the optimal method for screening for these abnormalities in the outpatient setting is unclear. METHODS AND RESULTS: The purpose of this review is to overview the prevalence and prognostic impact of AGR and IR in HF patients without DM and discuss potential pathophysiological pathways that link these conditions with HF. The severity of glucose intolerance in patients with HF correlates with functional and clinical severity of HF and is an independent predictor of an adverse outcome. It is thought that changes in cardiac metabolism, including a switch from glucose metabolism toward fatty acid metabolism, may in part contribute to the pathophysiological processes associated with HF patients with AGR/IR. CONCLUSIONS: We discuss how pharmacological targeting of metabolic pathways in the myocardium of these patients with HF may represent novel therapeutic strategies in these at-risk patients.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Mamas, Mamas A.
Deaton, Christi
Rutter, Martin K.
Yuille, Martin
Williams, Simon G.
Ray, Simon G.
New, John
Gibson, J. Martin
Neyses, Ludwig ;  University of Luxembourg > Research Office
Language :
English
Title :
Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?
Publication date :
2010
Journal title :
Journal of Cardiac Failure
ISSN :
1532-8414
Publisher :
Churchill Livingstone, United States - Pennsylvania
Volume :
16
Issue :
9
Pages :
761-8
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright 2010 Elsevier Inc. All rights reserved.
Available on ORBilu :
since 16 October 2014

Statistics


Number of views
70 (0 by Unilu)
Number of downloads
0 (0 by Unilu)

Scopus citations®
 
37
Scopus citations®
without self-citations
33
OpenCitations
 
32
WoS citations
 
29

Bibliography


Similar publications



Contact ORBilu